目錄多肽列表
ACE Inhibitors
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510107-0001 | Angiotensin I Converting Enzyme Inhibitor | RPGFSPFR | ≥95.0% | 1mg | ￥120 |
| T510107-0005 | Angiotensin I Converting Enzyme Inhibitor | RPGFSPFR | ≥95.0% | 5mg | ￥360 |
| T510108-0001 | Angiotensin Converting Enzyme Inhibitor | Glp-WPRPQIPP | ≥95.0% | 1mg | ￥135 |
| T510108-0005 | Angiotensin Converting Enzyme Inhibitor | Glp-WPRPQIPP | ≥95.0% | 5mg | ￥405 |
Acetalin
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510109-0001 | Acetalin-3 | Ac-RFMWMK-NH2 | ≥95.0% | 1mg | ￥110 |
| T510109-0005 | Acetalin-3 | Ac-RFMWMK-NH2 | ≥95.0% | 5mg | ￥330 |
| T510110-0001 | Acetalin-2 | Ac-RFMWMR-NH2 | ≥95.0% | 1mg | ￥110 |
| T510110-0005 | Acetalin-2 | Ac-RFMWMR-NH2 | ≥95.0% | 5mg | ￥330 |
| T510111-0001 | Acetalin-1 | Ac-RFMWMT-NH2 | ≥95.0% | 1mg | ￥110 |
| T510111-0005 | Acetalin-1 | Ac-RFMWMT-NH2 | ≥95.0% | 5mg | ￥330 |
Adrenocorticotropic Hormones (ACTH)
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510005-0001 | ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF | ≥95.0% | 1mg | ￥330 |
| T510005-0005 | ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF | ≥95.0% | 5mg | ￥990 |
| T510006-0001 | ACTH (6-24), human | HFRWGKPVGKKRRPVKVYP | ≥95.0% | 1mg | ￥285 |
| T510006-0005 | ACTH (6-24), human | HFRWGKPVGKKRRPVKVYP | ≥95.0% | 5mg | ￥285 |
| T510007-0001 | ACTH (4-10), human | MEHFRWG | ≥95.0% | 1mg | ￥105 |
| T510007-0005 | ACTH (4-10), human | MEHFRWG | ≥95.0% | 5mg | ￥315 |
| T510008-0001 | ACTH (4-11), human | MEHFRWGK | ≥95.0% | 1mg | ￥120 |
| T510008-0005 | ACTH (4-11), human | MEHFRWGK | ≥95.0% | 5mg | ￥360 |
| T510009-0001 | ACTH (1-10), human | SYSMEHFRWG | ≥95.0% | 1mg | ￥150 |
| T510009-0005 | ACTH (1-10), human | SYSMEHFRWG | ≥95.0% | 5mg | ￥450 |
| T510010-0001 | ACTH (1-13), human | SYSMEHFRWGKPV | ≥95.0% | 1mg | ￥165 |
| T510010-0005 | ACTH (1-13), human | SYSMEHFRWGKPV | ≥95.0% | 5mg | ￥495 |
| T510011-0001 | ACTH (1-16), human | SYSMEHFRWGKPVGKK | ≥95.0% | 1mg | ￥240 |
| T510011-0005 | ACTH (1-16), human | SYSMEHFRWGKPVGKK | ≥95.0% | 5mg | ￥720 |
| T510012-0001 | ACTH (1-17), human | SYSMEHFRWGKPVGKKR | ≥95.0% | 1mg | ￥255 |
| T510012-0005 | ACTH (1-17), human | SYSMEHFRWGKPVGKKR | ≥95.0% | 5mg | ￥765 |
| T510013-0001 | ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP | ≥95.0% | 1mg | ￥360 |
| T510013-0005 | ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP | ≥95.0% | 5mg | ￥1080 |
| T510014-0001 | ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF | ≥95.0% | 1mg | ￥624 |
| T510014-0005 | ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF | ≥95.0% | 5mg | ￥1872 |
| T510015-0001 | ACTH (1-39), rat | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF | ≥95.0% | 1mg | ￥624 |
| T510015-0005 | ACTH (1-39), rat | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF | ≥95.0% | 5mg | ￥1872 |
| T510112-0001 | N-Acetyl, ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR | ≥95.0% | 1mg | ￥255 |
| T510112-0005 | N-Acetyl, ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR | ≥95.0% | 5mg | ￥765 |
Adrenomedullins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510016-0001 | Pro-Adrenomedullin (N-20), rat | ARLDTSSQFRKKWNKWALSR-NH2 | ≥95.0% | 1mg | ￥312 |
| T510016-0005 | Pro-Adrenomedullin (N-20), rat | ARLDTSSQFRKKWNKWALSR-NH2 | ≥95.0% | 5mg | ￥936 |
| T510017-0001 | Pro-Adrenomedullin (N-20), porcine | ARLDVAAEFRKKWNKWALSR-NH2 | ≥95.0% | 1mg | ￥312 |
| T510017-0005 | Pro-Adrenomedullin (N-20), porcine | ARLDVAAEFRKKWNKWALSR-NH2 | ≥95.0% | 5mg | ￥936 |
| T510018-0001 | Pro-Adrenomedullin (N-20), human | ARLDVASEFRKKWNKWALSR-NH2 | ≥95.0% | 1mg | ￥312 |
| T510018-0005 | Pro-Adrenomedullin (N-20), human | ARLDVASEFRKKWNKWALSR-NH2 | ≥95.0% | 5mg | ￥936 |
| T510113-0001 | Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 | ≥95.0% | 1mg | ￥527 |
| T510113-0005 | Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 | ≥95.0% | 5mg | ￥1581 |
| T510115-0001 | Adrenomedullin (1-12), human | YRQSMNNFQGLR | ≥95.0% | 1mg | ￥120 |
| T510115-0005 | Adrenomedullin (1-12), human | YRQSMNNFQGLR | ≥95.0% | 5mg | ￥360 |
Allatostatins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510117-0001 | Allatostatins/Allatostatin I | APSGAQRLYGFGL-NH2 | ≥95.0% | 1mg | ￥205 |
| T510117-0005 | Allatostatins/Allatostatin I | APSGAQRLYGFGL-NH2 | ≥95.0% | 5mg | ￥615 |
| T510118-0001 | Allatostatin IV | DRLYSFGL-NH2 | ≥95.0% | 1mg | ￥130 |
| T510118-0005 | Allatostatin IV | DRLYSFGL-NH2 | ≥95.0% | 5mg | ￥390 |
| T510119-0001 | Allatostatin II | GDGRLYAFGL-NH2 | ≥95.0% | 1mg | ￥160 |
| T510119-0005 | Allatostatin II | GDGRLYAFGL-NH2 | ≥95.0% | 5mg | ￥480 |
| T510120-0001 | Allatostatin III | GGSLYSFGL-NH2 | ≥95.0% | 1mg | ￥145 |
| T510120-0005 | Allatostatin III | GGSLYSFGL-NH2 | ≥95.0% | 5mg | ￥435 |
Antibiotic Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510019-0001 | Magainin Spacer Peptide | DAEAVGPEAFADQDLDEREVR | ≥95.0% | 1mg | ￥316 |
| T510019-0005 | Magainin Spacer Peptide | DAEAVGPEAFADQDLDEREVR | ≥95.0% | 5mg | ￥948 |
| T510021-0001 | Histatin 5 | DSHAKRHHGYKRKFHEKHHSHRGY | ≥95.0% | 1mg | ￥360 |
| T510021-0005 | Histatin 5 | DSHAKRHHGYKRKFHEKHHSHRGY | ≥95.0% | 5mg | ￥1080 |
| T510121-0001 | Indolicidin | ILPWKWPWWPWRR-NH2 | ≥95.0% | 1mg | ￥205 |
| T510121-0005 | Indolicidin | ILPWKWPWWPWRR-NH2 | ≥95.0% | 5mg | ￥615 |
| T510122-0001 | Angiotensin III, human | RVYIHPF | ≥95.0% | 1mg | ￥105 |
| T510122-0005 | Angiotensin III, human | RVYIHPF | ≥95.0% | 5mg | ￥315 |
| T510123-0001 | Angiotensin II, human | DRVYIHPF | ≥95.0% | 1mg | ￥120 |
| T510123-0005 | Angiotensin II, human | DRVYIHPF | ≥95.0% | 5mg | ￥360 |
| T510124-0001 | Angiotensin I, human | DRVYIHPFHL | ≥95.0% | 1mg | ￥150 |
| T510124-0005 | Angiotensin I, human | DRVYIHPFHL | ≥95.0% | 5mg | ￥450 |
| T510125-0001 | CD36 Peptide P (139-155) | CNLAVAAASHIYQNQFVQ | ≥95.0% | 1mg | ￥255 |
| T510125-0005 | CD36 Peptide P (139-155) | CNLAVAAASHIYQNQFVQ | ≥95.0% | 5mg | ￥765 |
| T510126-0001 | Angiotensin II Antipeptide | EGVYVHPV | ≥95.0% | 1mg | ￥120 |
| T510126-0005 | Angiotensin II Antipeptide | EGVYVHPV | ≥95.0% | 5mg | ￥360 |
| T510127-0001 | Angiotensin II (5-8), human | IHPF | ≥95.0% | 1mg | ￥60 |
| T510127-0005 | Angiotensin II (5-8), human | IHPF | ≥95.0% | 5mg | ￥180 |
| T510128-0001 | CD36 Peptide P (93-110) | YRVRFLAKENVTQDAEDNC | ≥95.0% | 1mg | ￥270 |
| T510128-0005 | CD36 Peptide P (93-110) | YRVRFLAKENVTQDAEDNC | ≥95.0% | 5mg | ￥810 |
| T510131-0001 | Biotinyl-Angiotensin I | Biotin-DRVYIHPFHL | ≥95.0% | 1mg | ￥175 |
| T510131-0005 | Biotinyl-Angiotensin I | Biotin-DRVYIHPFHL | ≥95.0% | 5mg | ￥525 |
Anticoagulant and Antithrombotic Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510133-0001 | Fibrinogen-Binding Peptide | EHIPA | ≥95.0% | 1mg | ￥75 |
| T510133-0005 | Fibrinogen-Binding Peptide | EHIPA | ≥95.0% | 5mg | ￥225 |
Antimicrobial Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510023-0001 | Anti-Inflammatory Peptide 1 | MQMKKVLDS | ≥95.0% | 1mg | ￥135 |
| T510023-0005 | Anti-Inflammatory Peptide 1 | MQMKKVLDS | ≥95.0% | 5mg | ￥405 |
| T510024-0001 | Cecropin P1, porcine | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | ≥95.0% | 1mg | ￥480 |
| T510024-0005 | Cecropin P1, porcine | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | ≥95.0% | 5mg | ￥1440 |
| T510134-0001 | Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | KWKLFKKIGAVLKVL-NH2 | ≥95.0% | 1mg | ￥235 |
| T510134-0005 | Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | KWKLFKKIGAVLKVL-NH2 | ≥95.0% | 5mg | ￥705 |
| T510135-0001 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | ≥95.0% | 1mg | ￥368 |
| T510135-0005 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | ≥95.0% | 5mg | ￥1104 |
| T510136-0001 | Magainin I | GIGKFLHSAGKFGKAFVGEIMKS | ≥95.0% | 1mg | ￥368 |
| T510136-0005 | Magainin I | GIGKFLHSAGKFGKAFVGEIMKS | ≥95.0% | 5mg | ￥1104 |
| T510137-0001 | Lactoferricin, bovine, (BLFC) | RRWQWRMKKLG | ≥95.0% | 1mg | ￥165 |
| T510137-0005 | Lactoferricin, bovine, (BLFC) | RRWQWRMKKLG | ≥95.0% | 5mg | ￥495 |
Apelin Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510025-0001 | Apelin-13, human, bovine | QRPRLSHKGPMPF | ≥95.0% | 1mg | ￥195 |
| T510025-0005 | Apelin-13, human, bovine | QRPRLSHKGPMPF | ≥95.0% | 5mg | ￥585 |
| T510139-0001 | (Glp1)-Apelin-13, human, bovine | Glp-RPRLSHKGPMPF | ≥95.0% | 1mg | ￥220 |
| T510139-0005 | (Glp1)-Apelin-13, human, bovine | Glp-RPRLSHKGPMPF | ≥95.0% | 5mg | ￥660 |
Bag Cell Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510026-0001 | α-Bag Cell Peptide (1-7) | APRLRFY | ≥95.0% | 1mg | ￥105 |
| T510026-0005 | α-Bag Cell Peptide (1-7) | APRLRFY | ≥95.0% | 5mg | ￥315 |
| T510027-0001 | α-Bag Cell Peptide (1-8) | APRLRFYS | ≥95.0% | 1mg | ￥120 |
| T510027-0005 | α-Bag Cell Peptide (1-8) | APRLRFYS | ≥95.0% | 5mg | ￥360 |
| T510028-0001 | α-Bag Cell Peptide (1-9) | APRLRFYSL | ≥95.0% | 1mg | ￥135 |
| T510028-0005 | α-Bag Cell Peptide (1-9) | APRLRFYSL | ≥95.0% | 5mg | ￥405 |
| T510140-0001 | γ-Bag Cell Factor | RLRFD | ≥95.0% | 1mg | ￥75 |
| T510140-0005 | γ-Bag Cell Factor | RLRFD | ≥95.0% | 5mg | ￥225 |
| T510141-0001 | β-Bag Cell Factor | RLRFH | ≥95.0% | 1mg | ￥75 |
| T510141-0005 | β-Bag Cell Factor | RLRFH | ≥95.0% | 5mg | ￥225 |
β-Amyloid
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510142-0001 | β-Amyloid (1-14) | DAEFRHDSGYEVHH | ≥95.0% | 1mg | ￥280 |
| T510142-0005 | β-Amyloid (1-14) | DAEFRHDSGYEVHH | ≥95.0% | 5mg | ￥840 |
| T510143-0001 | β-Amyloid (1-13) | DAEFRHDSGYEVH | ≥95.0% | 1mg | ￥260 |
| T510143-0005 | β-Amyloid (1-13) | DAEFRHDSGYEVH | ≥95.0% | 5mg | ￥780 |
| T510144-0001 | β-Amyloid (1-12) | DAEFRHDSGYEV | ≥95.0% | 1mg | ￥240 |
| T510144-0005 | β-Amyloid (1-12) | DAEFRHDSGYEV | ≥95.0% | 5mg | ￥720 |
| T510145-0001 | β-Amyloid (1-11) | DAEFRHDSGYE | ≥95.0% | 1mg | ￥220 |
| T510145-0005 | β-Amyloid (1-11) | DAEFRHDSGYE | ≥95.0% | 5mg | ￥660 |
| T510146-0001 | β-Amyloid (1-10) | DAEFRHDSGY | ≥95.0% | 1mg | ￥200 |
| T510146-0005 | β-Amyloid (1-10) | DAEFRHDSGY | ≥95.0% | 5mg | ￥600 |
| T510147-0001 | β-Amyloid (1-9) | DAEFRHDSG | ≥95.0% | 1mg | ￥180 |
| T510147-0005 | β-Amyloid (1-9) | DAEFRHDSG | ≥95.0% | 5mg | ￥540 |
| T510148-0001 | β-Amyloid (1-20) | DAEFRHDSGYEVHHQKLVFF | ≥95.0% | 1mg | ￥400 |
| T510148-0005 | β-Amyloid (1-20) | DAEFRHDSGYEVHHQKLVFF | ≥95.0% | 5mg | ￥1200 |
| T510149-0001 | β-Amyloid (1-18) | DAEFRHDSGYEVHHQKLV | ≥95.0% | 1mg | ￥360 |
| T510149-0005 | β-Amyloid (1-18) | DAEFRHDSGYEVHHQKLV | ≥95.0% | 5mg | ￥1080 |
Bombesin
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510150-0001 | Bombesin | Glp-QRLGNQWAVGHLM-NH2 | ≥95.0% | 1mg | ￥254 |
| T510150-0005 | Bombesin | Glp-QRLGNQWAVGHLM-NH2 | ≥95.0% | 5mg | ￥762 |
Bone Gla Proteins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510029-0001 | Osteocalcin (37-49), human | GFQEAYRRFYGPV | ≥95.0% | 1mg | ￥195 |
| T510029-0005 | Osteocalcin (37-49), human | GFQEAYRRFYGPV | ≥95.0% | 5mg | ￥585 |
| T510030-0001 | Myelopeptide-2 (MP-2) | LVVYPW | ≥95.0% | 1mg | ￥90 |
| T510030-0005 | Myelopeptide-2 (MP-2) | LVVYPW | ≥95.0% | 5mg | ￥270 |
| T510031-0001 | Bone Gla Protein (45-49) | FYGPV | ≥95.0% | 1mg | ￥75 |
| T510031-0005 | Bone Gla Protein (45-49) | FYGPV | ≥95.0% | 5mg | ￥225 |
| T510151-0001 | [Tyr38, Phe42,46] Bone Gla Protein | YQEAFRRFFGPV | ≥95.0% | 1mg | ￥180 |
| T510151-0005 | [Tyr38, Phe42,46] Bone Gla Protein | YQEAFRRFFGPV | ≥95.0% | 5mg | ￥540 |
Bradykinins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510152-0001 | [Tyr0] Bradykinin | YRPPGFSPFR | ≥95.0% | 1mg | ￥150 |
| T510152-0005 | [Tyr0] Bradykinin | YRPPGFSPFR | ≥95.0% | 5mg | ￥450 |
| T510153-0001 | Bradykinin | RPPGFSPFR | ≥95.0% | 1mg | ￥135 |
| T510153-0005 | Bradykinin | RPPGFSPFR | ≥95.0% | 5mg | ￥405 |
| T510154-0001 | [Thi5,8,DPhe7] Bradykinin | RPPG-Thi-S-DPhe-Thi-R | ≥95.0% | 1mg | ￥210 |
| T510154-0005 | [Thi5,8,DPhe7] Bradykinin | RPPG-Thi-S-DPhe-Thi-R | ≥95.0% | 5mg | ￥630 |
| T510156-0001 | Fam-Bradykinin | 5FAM-RPPGFSPFR | ≥95.0% | 1mg | ￥235 |
| T510156-0005 | Fam-Bradykinin | 5FAM-RPPGFSPFR | ≥95.0% | 5mg | ￥705 |
CARTS
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510157-0001 | CART (55-76), rat | IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) | ≥95.0% | 1mg | ￥352 |
| T510157-0005 | CART (55-76), rat | IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) | ≥95.0% | 5mg | ￥1056 |
CCK
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510158-0001 | Cholecystokinin, CCK Tetrapeptide (30-33) | WMDF-NH2 | ≥95.0% | 1mg | ￥70 |
| T510158-0005 | Cholecystokinin, CCK Tetrapeptide (30-33) | WMDF-NH2 | ≥95.0% | 5mg | ￥210 |
| T510159-0001 | Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | DYMGWMDF-NH2 | ≥95.0% | 1mg | ￥130 |
| T510159-0005 | Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | DYMGWMDF-NH2 | ≥95.0% | 5mg | ￥390 |
CGRP
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510033-0001 | Katacalcin | DMSSDLERDHRPHVSMPQNAN | ≥95.0% | 1mg | ￥315 |
| T510033-0005 | Katacalcin | DMSSDLERDHRPHVSMPQNAN | ≥95.0% | 5mg | ￥945 |
| T510160-0001 | Calcitonin, rat | CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) | ≥95.0% | 1mg | ￥664 |
| T510160-0005 | Calcitonin, rat | CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) | ≥95.0% | 5mg | ￥1992 |
| T510161-0001 | Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) | ≥95.0% | 1mg | ￥664 |
| T510161-0005 | Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) | ≥95.0% | 5mg | ￥1992 |
CMV
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510162-0001 | Human CMV pp65 (495-503) | NLVPMVATV | ≥95.0% | 1mg | ￥135 |
| T510162-0005 | Human CMV pp65 (495-503) | NLVPMVATV | ≥95.0% | 5mg | ￥405 |
Corticotropin Releasing Factors
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510032-0001 | a-Helical Corticotropin Releasing Factor (12-41) | FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 | ≥95.0% | 1mg | ￥492 |
| T510032-0005 | a-Helical Corticotropin Releasing Factor (12-41) | FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 | ≥95.0% | 5mg | ￥1476 |
Cortistatins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510163-0001 | Cortistatin 29 (1-13) | Glp-ERPPLQQPPHRD | ≥95.0% | 1mg | ￥195 |
| T510163-0005 | Cortistatin 29 (1-13) | Glp-ERPPLQQPPHRD | ≥95.0% | 5mg | ￥585 |
C-Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510035-0001 | Proinsulin C-Peptide (55-89), ?human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR | ≥95.0% | 1mg | ￥630 |
| T510035-0005 | Proinsulin C-Peptide (55-89), ?human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR | ≥95.0% | 5mg | ￥1890 |
C-Type Natriuretic Peptides (CNP)
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510034-0001 | SMCY (950-960) (human) | SPSVDKARAEL | ≥95.0% | 1mg | ￥165 |
| T510034-0005 | SMCY (950-960) (human) | SPSVDKARAEL | ≥95.0% | 5mg | ￥495 |
Delta-Sleep Inducing Peptide (DSIP) and Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510164-0001 | Delta-Sleep Inducing Peptide | WAGGDASGE | ≥95.0% | 1mg | ￥135 |
| T510164-0005 | Delta-Sleep Inducing Peptide | WAGGDASGE | ≥95.0% | 5mg | ￥405 |
DISP
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510307-0001 | DISP | WAGGDASGE | ≥98.0% | 1mg | ￥162 |
| T510307-0005 | DISP | WAGGDASGE | ≥98.0% | 5mg | ￥486 |
Dynorphins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510165-0001 | Dynorphin A (2-17), porcine | GGFLRRIRPKLKWDNQ | ≥95.0% | 1mg | ￥240 |
| T510165-0005 | Dynorphin A (2-17), porcine | GGFLRRIRPKLKWDNQ | ≥95.0% | 5mg | ￥720 |
| T510166-0001 | Dynorphin (2-17), amide, porcine | GGFLRRIRPKLKWDNQ-NH2 | ≥95.0% | 1mg | ￥250 |
| T510166-0005 | Dynorphin (2-17), amide, porcine | GGFLRRIRPKLKWDNQ-NH2 | ≥95.0% | 5mg | ￥750 |
| T510167-0001 | Dynorphin B (1-9) | YGGFLRRQF | ≥95.0% | 1mg | ￥135 |
| T510167-0005 | Dynorphin B (1-9) | YGGFLRRQF | ≥95.0% | 5mg | ￥405 |
| T510168-0001 | Dynorphin A (1-13), porcine | YGGFLRRIRPKLK | ≥95.0% | 1mg | ￥195 |
| T510168-0005 | Dynorphin A (1-13), porcine | YGGFLRRIRPKLK | ≥95.0% | 5mg | ￥585 |
| T510169-0001 | Dynorphin A (1-13), amide, porcine | YGGFLRRIRPKLK-NH2 | ≥95.0% | 1mg | ￥205 |
| T510169-0005 | Dynorphin A (1-13), amide, porcine | YGGFLRRIRPKLK-NH2 | ≥95.0% | 5mg | ￥615 |
| T510170-0001 | Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ | ≥95.0% | 1mg | ￥255 |
| T510170-0005 | Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ | ≥95.0% | 5mg | ￥765 |
| T510171-0001 | Dynorphin A amide, porcine | YGGFLRRIRPKLKWDNQ-NH2 | ≥95.0% | 1mg | ￥265 |
| T510171-0005 | Dynorphin A amide, porcine | YGGFLRRIRPKLKWDNQ-NH2 | ≥95.0% | 5mg | ￥795 |
Endothelins and Related Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510036-0001 | IRL-1720 | Ac-DKEAVYFAHLDIIW | ≥95.0% | 1mg | ￥225 |
| T510036-0005 | IRL-1720 | Ac-DKEAVYFAHLDIIW | ≥95.0% | 5mg | ￥675 |
Enkephalins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510172-0001 | Met-Enkephalin | YGGFM | ≥95.0% | 1mg | ￥75 |
| T510172-0005 | Met-Enkephalin | YGGFM | ≥95.0% | 5mg | ￥225 |
Exendins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510037-0001 | EXENDIN (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | ≥95.0% | 1mg | ￥527 |
| T510037-0005 | EXENDIN (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | ≥95.0% | 5mg | ￥1581 |
| T510038-0001 | Exendin-4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | ≥95.0% | 1mg | ￥720 |
| T510038-0005 | Exendin-4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | ≥95.0% | 5mg | ￥2160 |
Fibronectin and Extra Cellular Matrix Related Peptide
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510173-0001 | Fibronectin CS1 Peptide | EILDVPST | ≥95.0% | 1mg | ￥120 |
| T510173-0005 | Fibronectin CS1 Peptide | EILDVPST | ≥95.0% | 5mg | ￥360 |
| T510174-0001 | G-R-G-D-S-P | GRGDSP | ≥95.0% | 1mg | ￥90 |
| T510174-0005 | G-R-G-D-S-P | GRGDSP | ≥95.0% | 5mg | ￥270 |
| T510175-0001 | Collagen Binding Fragment | CQDSETRTFY | ≥95.0% | 1mg | ￥150 |
| T510175-0005 | Collagen Binding Fragment | CQDSETRTFY | ≥95.0% | 5mg | ￥450 |
| T510176-0001 | [Glu1] Fibrinopeptide B, human | EGVNDNEEGFFSAR | ≥95.0% | 1mg | ￥210 |
| T510176-0005 | [Glu1] Fibrinopeptide B, human | EGVNDNEEGFFSAR | ≥95.0% | 5mg | ￥630 |
| T510177-0001 | [Tyr0] Fibrinopeptide A, human | YADSGEGDFLAEGGGVR | ≥95.0% | 1mg | ￥255 |
| T510177-0005 | [Tyr0] Fibrinopeptide A, human | YADSGEGDFLAEGGGVR | ≥95.0% | 5mg | ￥765 |
FMRF & Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510178-0001 | FMRF-amide | FMRF-NH2 | ≥95.0% | 1mg | ￥70 |
| T510178-0005 | FMRF-amide | FMRF-NH2 | ≥95.0% | 5mg | ￥210 |
Galanins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510179-0001 | Galantide | GWTLNSAGYLLGPQQFFGLM-NH2 | ≥95.0% | 1mg | ￥330 |
| T510179-0005 | Galantide | GWTLNSAGYLLGPQQFFGLM-NH2 | ≥95.0% | 5mg | ￥990 |
| T510180-0001 | Galanin, rat | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 | ≥95.0% | 1mg | ￥474 |
| T510180-0005 | Galanin, rat | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 | ≥95.0% | 5mg | ￥1422 |
| T510181-0001 | Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS | ≥95.0% | 1mg | ￥510 |
| T510181-0005 | Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS | ≥95.0% | 5mg | ￥1530 |
| T510182-0001 | M40 | GWTLNSAGYLLGPPPALALA-NH2 | ≥95.0% | 1mg | ￥310 |
| T510182-0005 | M40 | GWTLNSAGYLLGPPPALALA-NH2 | ≥95.0% | 5mg | ￥930 |
| T510183-0001 | M35 | GWTLNSAGYLLGPPPGFSPFR-NH2 | ≥95.0% | 1mg | ￥326 |
| T510183-0005 | M35 | GWTLNSAGYLLGPPPGFSPFR-NH2 | ≥95.0% | 5mg | ￥978 |
GHRF
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510184-0001 | GHRF (1-29), amide, rat | HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 | ≥95.0% | 1mg | ￥474 |
| T510184-0005 | GHRF (1-29), amide, rat | HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 | ≥95.0% | 5mg | ￥1422 |
| T510185-0001 | GHRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 | ≥95.0% | 1mg | ￥474 |
| T510185-0005 | GHRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 | ≥95.0% | 5mg | ￥1422 |
Glucagons and Glucagon-Like Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510039-0001 | GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG | ≥95.0% | 1mg | ￥527 |
| T510039-0005 | GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG | ≥95.0% | 5mg | ￥1581 |
| T510040-0001 | GLP-1 (7-36), amide, chicken, common turkey | HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 | ≥95.0% | 1mg | ￥510 |
| T510040-0005 | GLP-1 (7-36), amide, chicken, common turkey | HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 | ≥95.0% | 5mg | ￥1530 |
| T510041-0001 | GLP-1/Glucagon-Like Peptide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG | ≥95.0% | 1mg | ￥660 |
| T510041-0005 | GLP-1/Glucagon-Like Peptide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG | ≥95.0% | 5mg | ￥1980 |
| T510042-0001 | GLP-1/Glucagon-Like Peptide, amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | ≥95.0% | 1mg | ￥680 |
| T510042-0005 | GLP-1/Glucagon-Like Peptide, amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | ≥95.0% | 5mg | ￥2040 |
| T510043-0001 | [Des-His1,Glu9] Glucagon, amide | SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 | ≥95.0% | 1mg | ￥680 |
| T510043-0005 | [Des-His1,Glu9] Glucagon, amide | SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 | ≥95.0% | 5mg | ￥2040 |
| T510186-0001 | GLP-2, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITD | ≥95.0% | 1mg | ￥561 |
| T510186-0005 | GLP-2, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITD | ≥95.0% | 5mg | ￥1683 |
| T510187-0001 | Glucagon-Like Peptide II, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR | ≥95.0% | 1mg | ￥578 |
| T510187-0005 | Glucagon-Like Peptide II, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR | ≥95.0% | 5mg | ￥1734 |
| T510188-0001 | Glucagon-Like Peptide II, rat | HADGSFSDEMNTILDNLATRDFINWLIQTKITD | ≥95.0% | 1mg | ￥561 |
| T510188-0005 | Glucagon-Like Peptide II, rat | HADGSFSDEMNTILDNLATRDFINWLIQTKITD | ≥95.0% | 5mg | ￥1683 |
| T510189-0001 | Glucagon, human | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT | ≥95.0% | 1mg | ￥464 |
| T510189-0005 | Glucagon, human | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT | ≥95.0% | 5mg | ￥1392 |
Growth Factor Fragments
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510045-0001 | Epidermal Growth Factor Receptor Peptide (985-996) | DVVDADEYLIPQ | ≥95.0% | 1mg | ￥180 |
| T510045-0005 | Epidermal Growth Factor Receptor Peptide (985-996) | DVVDADEYLIPQ | ≥95.0% | 5mg | ￥540 |
| T510047-0001 | Brain Derived Acidic Fibroblast Growth Factor (1-11) | FNLPLGNYKKP | ≥95.0% | 1mg | ￥165 |
| T510047-0005 | Brain Derived Acidic Fibroblast Growth Factor (1-11) | FNLPLGNYKKP | ≥95.0% | 5mg | ￥495 |
| T510049-0001 | Brain Derived Basic Fibroblast Growth Factor (1-24) | PALPEDGGSGAFPPGHFKDPKRLY | ≥95.0% | 1mg | ￥360 |
| T510049-0005 | Brain Derived Basic Fibroblast Growth Factor (1-24) | PALPEDGGSGAFPPGHFKDPKRLY | ≥95.0% | 5mg | ￥1080 |
| T510190-0001 | Brain Derived Acidic Fibroblast Growth Factor (102-111) | HAEKHWFVGL | ≥95.0% | 1mg | ￥150 |
| T510190-0005 | Brain Derived Acidic Fibroblast Growth Factor (102-111) | HAEKHWFVGL | ≥95.0% | 5mg | ￥450 |
GTP-Binding Protein Fragments
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510191-0001 | GTP-Binding Protein Fragment, Gs alpha | CKQLQKDKQVYRATHR | ≥95.0% | 1mg | ￥240 |
| T510191-0005 | GTP-Binding Protein Fragment, Gs alpha | CKQLQKDKQVYRATHR | ≥95.0% | 5mg | ￥720 |
Histone H1 Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510192-0001 | Histone H1-derived Peptide | GGGPATPKKAKKL | ≥95.0% | 1mg | ￥165 |
| T510192-0005 | Histone H1-derived Peptide | GGGPATPKKAKKL | ≥95.0% | 5mg | ￥495 |
HIV related peptide
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510050-0001 | HIV-1 tat Protein (1-9) | MDPVDPNIE | ≥95.0% | 1mg | ￥135 |
| T510050-0005 | HIV-1 tat Protein (1-9) | MDPVDPNIE | ≥95.0% | 5mg | ￥405 |
| T510193-0001 | HIV-1 gag Protein p24 (194-210) | ANPDCKTILKALGPAAT | ≥95.0% | 1mg | ￥255 |
| T510193-0005 | HIV-1 gag Protein p24 (194-210) | ANPDCKTILKALGPAAT | ≥95.0% | 5mg | ￥765 |
| T510194-0001 | HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | AVGIGALFLGFLGAAGSTMGARS-NH2 | ≥95.0% | 1mg | ￥378 |
| T510194-0005 | HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | AVGIGALFLGFLGAAGSTMGARS-NH2 | ≥95.0% | 5mg | ￥1134 |
| T510195-0001 | HIV (gp41) Fragment | AVGIGA | ≥95.0% | 1mg | ￥120 |
| T510195-0005 | HIV (gp41) Fragment | AVGIGA | ≥95.0% | 5mg | ￥360 |
| T510196-0001 | HIV (gp120) Fragment (318-327) | RGPGRAFVTI | ≥95.0% | 1mg | ￥150 |
| T510196-0005 | HIV (gp120) Fragment (318-327) | RGPGRAFVTI | ≥95.0% | 5mg | ￥450 |
| T510197-0001 | HIV-1 tat Protein (49-57) | RKKRRQRRR | ≥95.0% | 1mg | ￥135 |
| T510197-0005 | HIV-1 tat Protein (49-57) | RKKRRQRRR | ≥95.0% | 5mg | ￥405 |
Laminin Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510051-0001 | Laminin (925-933) | CDPGYIGSR | ≥95.0% | 1mg | ￥135 |
| T510051-0005 | Laminin (925-933) | CDPGYIGSR | ≥95.0% | 5mg | ￥405 |
| T510052-0001 | Laminin A Chain (2091-2108) | CSRARKQAASIKVAVSADR | ≥95.0% | 1mg | ￥270 |
| T510052-0005 | Laminin A Chain (2091-2108) | CSRARKQAASIKVAVSADR | ≥95.0% | 5mg | ￥810 |
| T510198-0001 | Laminin (929-933) | YIGSR | ≥95.0% | 1mg | ￥75 |
| T510198-0005 | Laminin (929-933) | YIGSR | ≥95.0% | 5mg | ￥225 |
| T510199-0001 | Laminin Penta Peptide, amide | YIGSR-NH2 | ≥95.0% | 1mg | ￥85 |
| T510199-0005 | Laminin Penta Peptide, amide | YIGSR-NH2 | ≥95.0% | 5mg | ￥255 |
Leptin Fragment Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510053-0001 | Leptin (93-105), human | NVIQISNDLENLR | ≥95.0% | 1mg | ￥195 |
| T510053-0005 | Leptin (93-105), human | NVIQISNDLENLR | ≥95.0% | 5mg | ￥585 |
| T510200-0001 | Leptin (116-130), mouse | SCSLPQTSGLQKPES | ≥95.0% | 1mg | ￥225 |
| T510200-0005 | Leptin (116-130), mouse | SCSLPQTSGLQKPES | ≥95.0% | 5mg | ￥675 |
Leucokinins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510201-0001 | Leucokinin I | DPAFNSWG | ≥95.0% | 1mg | ￥130 |
| T510201-0005 | Leucokinin I | DPAFNSWG | ≥95.0% | 5mg | ￥390 |
LH-RH & Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510202-0001 | [DTrp6]-LH-RH, amide | Glp-HWSY-DTrp-LRPG-NH2 | ≥95.0% | 1mg | ￥210 |
| T510202-0005 | [DTrp6]-LH-RH, amide | Glp-HWSY-DTrp-LRPG-NH2 | ≥95.0% | 5mg | ￥630 |
| T510203-0001 | LH-RH, Free Acid | Glp-HWSYGLRPG | ≥95.0% | 1mg | ￥165 |
| T510203-0005 | LH-RH, Free Acid | Glp-HWSYGLRPG | ≥95.0% | 5mg | ￥495 |
| T510204-0001 | LH-RH, human, Gonadoreline | Glp-HWSYGLRPG-NH2 | ≥95.0% | 1mg | ￥175 |
| T510204-0005 | LH-RH, human, Gonadoreline | Glp-HWSYGLRPG-NH2 | ≥95.0% | 5mg | ￥525 |
| T510205-0001 | LH-RH, salmon | Glp-HWSYGWLPG-NH2 | ≥95.0% | 1mg | ￥175 |
| T510205-0005 | LH-RH, salmon | Glp-HWSYGWLPG-NH2 | ≥95.0% | 5mg | ￥525 |
| T510206-0001 | LH-RH, lamprey | Glp-HYSLEWKPG-NH2 | ≥95.0% | 1mg | ￥175 |
| T510206-0005 | LH-RH, lamprey | Glp-HYSLEWKPG-NH2 | ≥95.0% | 5mg | ￥525 |
Mast Cell Degranulating Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510054-0001 | Mast Cell Degranulating Peptide HR-1 | INLKAIAALVKKVL-NH2 | ≥95.0% | 1mg | ￥225 |
| T510054-0005 | Mast Cell Degranulating Peptide HR-1 | INLKAIAALVKKVL-NH2 | ≥95.0% | 5mg | ￥675 |
| T510055-0001 | Mast Cell Degranulating Peptide HR-2 | FLPLILGKLVKGLL-NH2 | ≥95.0% | 1mg | ￥225 |
| T510055-0005 | Mast Cell Degranulating Peptide HR-2 | FLPLILGKLVKGLL-NH2 | ≥95.0% | 5mg | ￥675 |
Melanocyte-Stimulating Hormone-Release Inhibiting
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510056-0001 | Melanocyte-Stimulating Hormone-Release Inhibiting Factor | PLG-NH2 | ≥95.0% | 1mg | ￥55 |
| T510056-0005 | Melanocyte-Stimulating Hormone-Release Inhibiting Factor | PLG-NH2 | ≥95.0% | 5mg | ￥165 |
Melanoma Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510057-0001 | MAGE-3 Antigen (167-176), human | MEVDPIGHLY | ≥95.0% | 1mg | ￥150 |
| T510057-0005 | MAGE-3 Antigen (167-176), human | MEVDPIGHLY | ≥95.0% | 5mg | ￥450 |
| T510058-0001 | MAGE-3 Antigen (271-279), human | FLWGPRALV | ≥95.0% | 1mg | ￥135 |
| T510058-0005 | MAGE-3 Antigen (271-279), human | FLWGPRALV | ≥95.0% | 5mg | ￥405 |
| T510207-0001 | Mage-1 Antigen (161-169), human | EADPTGHSY | ≥95.0% | 1mg | ￥135 |
| T510207-0005 | Mage-1 Antigen (161-169), human | EADPTGHSY | ≥95.0% | 5mg | ￥405 |
| T510208-0001 | (Met 210) Melanoctye Protein PMEL 17 (209-217) (human) | IMDQVPFSV | ≥95.0% | 1mg | ￥135 |
| T510208-0005 | (Met 210) Melanoctye Protein PMEL 17 (209-217) (human) | IMDQVPFSV | ≥95.0% | 5mg | ￥405 |
| T510209-0001 | Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | ITDQVPFSV | ≥95.0% | 1mg | ￥135 |
| T510209-0005 | Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | ITDQVPFSV | ≥95.0% | 5mg | ￥405 |
| T510210-0001 | Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | WNRQLYPEWTEAQRLD | ≥95.0% | 1mg | ￥240 |
| T510210-0005 | Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | WNRQLYPEWTEAQRLD | ≥95.0% | 5mg | ￥720 |
Miscellaneous Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510059-0001 | Systemin | AVQSKPPSKRDPPKMQTD | ≥95.0% | 1mg | ￥270 |
| T510059-0005 | Systemin | AVQSKPPSKRDPPKMQTD | ≥95.0% | 5mg | ￥810 |
| T510060-0001 | Flag Peptide | DYKDDDDK | ≥95.0% | 1mg | ￥120 |
| T510060-0005 | Flag Peptide | DYKDDDDK | ≥95.0% | 5mg | ￥360 |
| T510211-0001 | OVA 323-339 | ISQAVHAAHAEINEAGR | ≥95.0% | 1mg | ￥272 |
| T510211-0005 | OVA 323-339 | ISQAVHAAHAEINEAGR | ≥95.0% | 5mg | ￥816 |
| T510212-0001 | OVA peptide (257-264) | SIINFEKL | ≥95.0% | 1mg | ￥120 |
| T510212-0005 | OVA peptide (257-264) | SIINFEKL | ≥95.0% | 5mg | ￥360 |
| T510213-0001 | Myelin Basic Protein (68-84), guinea pig | YGSLPQKSQRSQDEN | ≥95.0% | 1mg | ￥225 |
| T510213-0005 | Myelin Basic Protein (68-84), guinea pig | YGSLPQKSQRSQDEN | ≥95.0% | 5mg | ￥675 |
| T510214-0001 | Hexa His | HHHHHH | ≥95.0% | 1mg | ￥120 |
| T510214-0005 | Hexa His | HHHHHH | ≥95.0% | 5mg | ￥360 |
Motilins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510219-0001 | MOG 35-55 | MEVGWYRSPFSRVVHLYRNGK | ≥95.0% | 1mg | ￥336 |
| T510219-0005 | MOG 35-55 | MEVGWYRSPFSRVVHLYRNGK | ≥95.0% | 5mg | ￥1008 |
| T510220-0001 | Motilin, canine | FVPIFTHSELQKIREKERNKGQ | ≥95.0% | 1mg | ￥330 |
| T510220-0005 | Motilin, canine | FVPIFTHSELQKIREKERNKGQ | ≥95.0% | 5mg | ￥990 |
| T510221-0001 | Motilin, human, porcine | FVPIFTYGELQRMQEKERNKGQ | ≥95.0% | 1mg | ￥352 |
| T510221-0005 | Motilin, human, porcine | FVPIFTYGELQRMQEKERNKGQ | ≥95.0% | 5mg | ￥1056 |
Myelin Basic Protein Fragments and Antagonists
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510061-0001 | Myelin Basic Protein (87-99) (human, bovine, rat) | VHFFKNIVTPRTP | ≥95.0% | 1mg | ￥195 |
| T510061-0005 | Myelin Basic Protein (87-99) (human, bovine, rat) | VHFFKNIVTPRTP | ≥95.0% | 5mg | ￥585 |
Neurokinins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510001-0001 | Neurokinin B | DMHDFFVGLM-NH2 | ≥95.0% | 1mg | ￥165 |
| T510001-0005 | Neurokinin B | DMHDFFVGLM-NH2 | ≥95.0% | 5mg | ￥495 |
| T510222-0001 | Neurokinin A / Substance K | HKTDSFVGLM-NH2 | ≥95.0% | 1mg | ￥160 |
| T510222-0005 | Neurokinin A / Substance K | HKTDSFVGLM-NH2 | ≥95.0% | 5mg | ￥480 |
Neuromedins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510223-0001 | Neuromedin C | GNHWAVGHLM-NH2 | ≥95.0% | 1mg | ￥160 |
| T510223-0005 | Neuromedin C | GNHWAVGHLM-NH2 | ≥95.0% | 5mg | ￥480 |
| T510224-0001 | Neuromedin B | GNLWATGHFM-NH2 | ≥95.0% | 1mg | ￥160 |
| T510224-0005 | Neuromedin B | GNLWATGHFM-NH2 | ≥95.0% | 5mg | ￥480 |
| T510225-0001 | Neuromedin N | KIPYIL | ≥95.0% | 1mg | ￥90 |
| T510225-0005 | Neuromedin N | KIPYIL | ≥95.0% | 5mg | ￥270 |
| T510226-0001 | Neuromedin (U25), human | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 | ≥95.0% | 1mg | ￥400 |
| T510226-0005 | Neuromedin (U25), human | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 | ≥95.0% | 5mg | ￥1200 |
Neuropeptide Y & Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510062-0001 | Neuropeptide Y, human | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 | ≥95.0% | 1mg | ￥664 |
| T510062-0005 | Neuropeptide Y, human | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 | ≥95.0% | 5mg | ￥1992 |
| T510063-0001 | Neuropeptide Y (13-36), human | PAEDMARYYSALRHYINLITRQRY-NH2 | ≥95.0% | 1mg | ￥360 |
| T510063-0005 | Neuropeptide Y (13-36), human | PAEDMARYYSALRHYINLITRQRY-NH2 | ≥95.0% | 5mg | ￥1080 |
Neuropeptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510002-0001 | Neuropeptide K, porcine | DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 | ≥95.0% | 1mg | ￥598 |
| T510002-0005 | Neuropeptide K, porcine | DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 | ≥95.0% | 5mg | ￥1794 |
| T510003-0001 | Kassinin | DVPKSDQFVGLM-NH2 | ≥95.0% | 1mg | ￥195 |
| T510003-0005 | Kassinin | DVPKSDQFVGLM-NH2 | ≥95.0% | 5mg | ￥585 |
| T510004-0001 | Nocistatin | EQKQLQ | ≥95.0% | 1mg | ￥90 |
| T510004-0005 | Nocistatin | EQKQLQ | ≥95.0% | 5mg | ￥270 |
| T510227-0001 | Mastoparan | INLKALAALAKKIL-NH2 | ≥95.0% | 1mg | ￥220 |
| T510227-0005 | Mastoparan | INLKALAALAKKIL-NH2 | ≥95.0% | 5mg | ￥660 |
| T510228-0001 | Mastoparan X | INWKGIAAMAKKLL-NH2 | ≥95.0% | 1mg | ￥220 |
| T510228-0005 | Mastoparan X | INWKGIAAMAKKLL-NH2 | ≥95.0% | 5mg | ￥660 |
| T510229-0001 | Neuropeptide FF | FLFQPQRF-NH2 | ≥95.0% | 1mg | ￥130 |
| T510229-0005 | Neuropeptide FF | FLFQPQRF-NH2 | ≥95.0% | 5mg | ￥390 |
| T510231-0001 | Diazepam-Binding Inhibitor Fragment, human | QATVGDINTERPGMLDFTGK | ≥95.0% | 1mg | ￥320 |
| T510231-0005 | Diazepam-Binding Inhibitor Fragment, human | QATVGDINTERPGMLDFTGK | ≥95.0% | 5mg | ￥960 |
| T510232-0001 | Men 10376 | DY-DTrp-V-DTrp-DTrp-K-NH2 | ≥95.0% | 1mg | ￥205 |
| T510232-0005 | Men 10376 | DY-DTrp-V-DTrp-DTrp-K-NH2 | ≥95.0% | 5mg | ￥615 |
| T510233-0001 | Physalaemin | Glp-ADPNKFYGLM-NH2 | ≥95.0% | 1mg | ￥205 |
| T510233-0005 | Physalaemin | Glp-ADPNKFYGLM-NH2 | ≥95.0% | 5mg | ￥615 |
| T510234-0001 | Phyllomedusin | Glp-NPNRFIGLM-NH2 | ≥95.0% | 1mg | ￥190 |
| T510234-0005 | Phyllomedusin | Glp-NPNRFIGLM-NH2 | ≥95.0% | 5mg | ￥570 |
| T510235-0001 | Corazonin | Glp-TFQYSRGWTN-NH2 | ≥95.0% | 1mg | ￥205 |
| T510235-0005 | Corazonin | Glp-TFQYSRGWTN-NH2 | ≥95.0% | 5mg | ￥615 |
Neurotensins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510236-0001 | Neurotensin (8-13) | RRPYIL | ≥95.0% | 1mg | ￥90 |
| T510236-0005 | Neurotensin (8-13) | RRPYIL | ≥95.0% | 5mg | ￥270 |
Obestatins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510237-0001 | Obestatin (human) | FNAPFDVGIKLSGVQYQQHSQAL-NH2 | ≥95.0% | 1mg | ￥378 |
| T510237-0005 | Obestatin (human) | FNAPFDVGIKLSGVQYQQHSQAL-NH2 | ≥95.0% | 5mg | ￥1134 |
Opioid Related Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510064-0001 | Nociceptin / Orphanin FQ | FGGFTGARKSARKLANQ | ≥95.0% | 1mg | ￥254 |
| T510064-0005 | Nociceptin / Orphanin FQ | FGGFTGARKSARKLANQ | ≥95.0% | 5mg | ￥762 |
Orexins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510238-0001 | Orexin B, canine | RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 | ≥95.0% | 1mg | ￥458 |
| T510238-0005 | Orexin B, canine | RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 | ≥95.0% | 5mg | ￥1374 |
| T510239-0001 | Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 | ≥95.0% | 1mg | ￥458 |
| T510239-0005 | Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 | ≥95.0% | 5mg | ￥1374 |
PACAP
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510065-0001 | PACAP (1-38), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 | ≥95.0% | 1mg | ￥684 |
| T510065-0005 | PACAP (1-38), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 | ≥95.0% | 5mg | ￥2052 |
| T510066-0001 | PACAP-Related Peptide (PRP), rat | DVAHEILNEAYRKVLDQLSARKYLQSMVA | ≥95.0% | 1mg | ￥464 |
| T510066-0005 | PACAP-Related Peptide (PRP), rat | DVAHEILNEAYRKVLDQLSARKYLQSMVA | ≥95.0% | 5mg | ￥1392 |
| T510067-0001 | PACAP-Related Peptide (PRP), human | DVAHGILNEAYRKVLDQLSAGKHLQSLVA | ≥95.0% | 1mg | ￥464 |
| T510067-0005 | PACAP-Related Peptide (PRP), human | DVAHGILNEAYRKVLDQLSAGKHLQSLVA | ≥95.0% | 5mg | ￥1392 |
| T510240-0001 | PACAP (1-27), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 | ≥95.0% | 1mg | ￥442 |
| T510240-0005 | PACAP (1-27), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 | ≥95.0% | 5mg | ￥1326 |
| T510241-0001 | PACAP (6-27), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVL-NH2 | ≥95.0% | 1mg | ￥362 |
| T510241-0005 | PACAP (6-27), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVL-NH2 | ≥95.0% | 5mg | ￥1086 |
Pancreastatin & Related Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510068-0001 | Chromostatin, bovine | SDEDSDGDRPQASPGLGPGP | ≥95.0% | 1mg | ￥300 |
| T510068-0005 | Chromostatin, bovine | SDEDSDGDRPQASPGLGPGP | ≥95.0% | 5mg | ￥900 |
Pancreatic Polypeptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510069-0001 | Pancreatic Polypeptide (rat) | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 | ≥95.0% | 1mg | ￥684 |
| T510069-0005 | Pancreatic Polypeptide (rat) | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 | ≥95.0% | 5mg | ￥2052 |
| T510070-0001 | Pancreatic Polypeptide (human) | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 | ≥95.0% | 1mg | ￥684 |
| T510070-0005 | Pancreatic Polypeptide (human) | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 | ≥95.0% | 5mg | ￥2052 |
| T510071-0001 | Insulin B (9 - 23) | SHLVEALYLVCGERG | ≥95.0% | 1mg | ￥210 |
| T510071-0005 | Insulin B (9 - 23) | SHLVEALYLVCGERG | ≥95.0% | 5mg | ￥630 |
PAR Peptides and Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510242-0001 | PAR - 1 Agonist;Protease - Activated Receptor - 1 | TFLLRN | ≥95.0% | 1mg | ￥90 |
| T510242-0005 | PAR - 1 Agonist;Protease - Activated Receptor - 1 | TFLLRN | ≥95.0% | 5mg | ￥270 |
| T510243-0001 | PAR-4 (1-6) amide (human) | GYPGQV-NH2 | ≥95.0% | 1mg | ￥100 |
| T510243-0005 | PAR-4 (1-6) amide (human) | GYPGQV-NH2 | ≥95.0% | 5mg | ￥300 |
| T510244-0001 | PAR-4 (1-6) (human) | GYPGQV | ≥95.0% | 1mg | ￥90 |
| T510244-0005 | PAR-4 (1-6) (human) | GYPGQV | ≥95.0% | 5mg | ￥270 |
| T510245-0001 | PAR-4 (1-6) amide (mouse) | GYPGKF-NH2 | ≥95.0% | 1mg | ￥100 |
| T510245-0005 | PAR-4 (1-6) amide (mouse) | GYPGKF-NH2 | ≥95.0% | 5mg | ￥300 |
| T510246-0001 | PAR-4 (1-6) (mouse) | GYPGKF | ≥95.0% | 1mg | ￥90 |
| T510246-0005 | PAR-4 (1-6) (mouse) | GYPGKF | ≥95.0% | 5mg | ￥270 |
Protein Kinase and Related Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510072-0001 | P34cdc2 Kinase Substrate Peptide | ADAQHATPPKKKRKVEDPKDF | ≥95.0% | 1mg | ￥315 |
| T510072-0005 | P34cdc2 Kinase Substrate Peptide | ADAQHATPPKKKRKVEDPKDF | ≥95.0% | 5mg | ￥945 |
| T510073-0001 | Tyrosinase (206-214), human | AFLPWHRLF | ≥95.0% | 1mg | ￥136 |
| T510073-0005 | Tyrosinase (206-214), human | AFLPWHRLF | ≥95.0% | 5mg | ￥408 |
| T510074-0001 | Substrate for Tyrosine Protein Kinase | RRLIEDNEYTARG | ≥95.0% | 1mg | ￥194 |
| T510074-0005 | Substrate for Tyrosine Protein Kinase | RRLIEDNEYTARG | ≥95.0% | 5mg | ￥582 |
| T510075-0001 | S6-1 | RRLSSLRA | ≥95.0% | 1mg | ￥122 |
| T510075-0005 | S6-1 | RRLSSLRA | ≥95.0% | 5mg | ￥366 |
| T510076-0001 | Phosphate Acceptor Peptide | RRKASGPPV | ≥95.0% | 1mg | ￥136 |
| T510076-0005 | Phosphate Acceptor Peptide | RRKASGPPV | ≥95.0% | 5mg | ￥408 |
| T510077-0001 | Malantide | RTKRSGSVYEPLKI | ≥95.0% | 1mg | ￥210 |
| T510077-0005 | Malantide | RTKRSGSVYEPLKI | ≥95.0% | 5mg | ￥630 |
| T510078-0001 | QKRPSQRSKYL | QKRPSQRSKYL | ≥95.0% | 1mg | ￥150 |
| T510078-0005 | QKRPSQRSKYL | QKRPSQRSKYL | ≥95.0% | 5mg | ￥450 |
| T510079-0001 | Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 | ≥95.0% | 1mg | ￥110 |
| T510079-0005 | Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 | ≥95.0% | 5mg | ￥330 |
| T510247-0001 | Melittin | GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 | ≥95.0% | 1mg | ￥426 |
| T510247-0005 | Melittin | GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 | ≥95.0% | 5mg | ￥1278 |
| T510248-0001 | Kemptide | LRRASLG | ≥95.0% | 1mg | ￥90 |
| T510248-0005 | Kemptide | LRRASLG | ≥95.0% | 5mg | ￥270 |
| T510249-0001 | Phosphorylase Kinase b-Subunit (420-436) | KRNPGSQKRFPSNCGRD | ≥95.0% | 1mg | ￥255 |
| T510249-0005 | Phosphorylase Kinase b-Subunit (420-436) | KRNPGSQKRFPSNCGRD | ≥95.0% | 5mg | ￥765 |
| T510251-0001 | Myosin Kinase Inhibiting Peptide | KKRAARATS-NH2 | ≥95.0% | 1mg | ￥145 |
| T510251-0005 | Myosin Kinase Inhibiting Peptide | KKRAARATS-NH2 | ≥95.0% | 5mg | ￥435 |
| T510252-0001 | Syntide 2 | PLARTLSVAGLPGKK | ≥95.0% | 1mg | ￥225 |
| T510252-0005 | Syntide 2 | PLARTLSVAGLPGKK | ≥95.0% | 5mg | ￥675 |
| T510253-0001 | Tyrosinase (192-200), human mouse | SEIWRDIDF | ≥95.0% | 1mg | ￥135 |
| T510253-0005 | Tyrosinase (192-200), human mouse | SEIWRDIDF | ≥95.0% | 5mg | ￥405 |
| T510255-0001 | Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | YIYGSFK | ≥95.0% | 1mg | ￥105 |
| T510255-0005 | Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | YIYGSFK | ≥95.0% | 5mg | ￥315 |
| T510256-0001 | Casein Kinase II Substrate | RRREEETEEE | ≥95.0% | 1mg | ￥210 |
| T510256-0005 | Casein Kinase II Substrate | RRREEETEEE | ≥95.0% | 5mg | ￥630 |
| T510257-0001 | RREEETEEE | RREEETEEE | ≥95.0% | 1mg | ￥189 |
| T510257-0005 | RREEETEEE | RREEETEEE | ≥95.0% | 5mg | ￥567 |
| T510259-0001 | Ser25] Protein Kinase C (19-31) | RFARKGSLRQKNV | ≥95.0% | 1mg | ￥195 |
| T510259-0005 | Ser25] Protein Kinase C (19-31) | RFARKGSLRQKNV | ≥95.0% | 5mg | ￥585 |
| T510261-0001 | [Ala9] Autocamtide 2 | KKALRRQEAVDAL | ≥95.0% | 1mg | ￥195 |
| T510261-0005 | [Ala9] Autocamtide 2 | KKALRRQEAVDAL | ≥95.0% | 5mg | ￥585 |
| T510262-0001 | Autocamtide 2 | KKALRRQETVDAL | ≥95.0% | 1mg | ￥195 |
| T510262-0005 | Autocamtide 2 | KKALRRQETVDAL | ≥95.0% | 5mg | ￥585 |
| T510263-0001 | cAMP Dependent PK Inhibitor (5-22), amide | TTYADFIASGRTGRRNAI-NH2 | ≥95.0% | 1mg | ￥280 |
| T510263-0005 | cAMP Dependent PK Inhibitor (5-22), amide | TTYADFIASGRTGRRNAI-NH2 | ≥95.0% | 5mg | ￥840 |
| T510264-0001 | RR-SRC | RRLIEDAEYAARG | ≥95.0% | 1mg | ￥195 |
| T510264-0005 | RR-SRC | RRLIEDAEYAARG | ≥95.0% | 5mg | ￥585 |
| T510265-0001 | Protein Kinase C (19-35) Peptide | RFARKGALRQKNVHEVK | ≥95.0% | 1mg | ￥255 |
| T510265-0005 | Protein Kinase C (19-35) Peptide | RFARKGALRQKNVHEVK | ≥95.0% | 5mg | ￥765 |
| T510267-0001 | Protein Kinase C (gamma) Peptide | NYPLELYERVRTGC | ≥95.0% | 1mg | ￥210 |
| T510267-0005 | Protein Kinase C (gamma) Peptide | NYPLELYERVRTGC | ≥95.0% | 5mg | ￥630 |
Protein Kinases Substrate
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510269-0001 | 5FAM-RQMSFRL | 5FAM-RQMSFRL | ≥95.0% | 1mg | ￥276 |
| T510269-0005 | 5FAM-RQMSFRL | 5FAM-RQMSFRL | ≥95.0% | 5mg | ￥828 |
| T510270-0001 | 5FAM-RKRRQTSM | 5FAM-RKRRQTSM | ≥95.0% | 1mg | ￥294 |
| T510270-0005 | 5FAM-RKRRQTSM | 5FAM-RKRRQTSM | ≥95.0% | 5mg | ￥882 |
| T510271-0001 | 5FAM-RKRSRAEA-NH2 | 5FAM-RKRSRAEA-NH2 | ≥95.0% | 1mg | ￥304 |
| T510271-0005 | 5FAM-RKRSRAEA-NH2 | 5FAM-RKRSRAEA-NH2 | ≥95.0% | 5mg | ￥912 |
| T510272-0001 | 5FAM-RPRTSSF | 5FAM-RPRTSSF | ≥95.0% | 1mg | ￥276 |
| T510272-0005 | 5FAM-RPRTSSF | 5FAM-RPRTSSF | ≥95.0% | 5mg | ￥828 |
| T510273-0001 | 5FAM-RTKRSGSVYEPLKI-NH2 | 5FAM-RTKRSGSVYEPLKI-NH2 | ≥95.0% | 1mg | ￥420 |
| T510273-0005 | 5FAM-RTKRSGSVYEPLKI-NH2 | 5FAM-RTKRSGSVYEPLKI-NH2 | ≥95.0% | 5mg | ￥1260 |
| T510274-0001 | 5FAM-NVKSKIGSTENLK-NH2 | 5FAM-NVKSKIGSTENLK-NH2 | ≥95.0% | 1mg | ￥402 |
| T510274-0005 | 5FAM-NVKSKIGSTENLK-NH2 | 5FAM-NVKSKIGSTENLK-NH2 | ≥95.0% | 5mg | ￥402 |
| T510275-0001 | 5FAM-DEEIYEELK-NH2 | 5FAM-DEEIYEELK-NH2 | ≥95.0% | 1mg | ￥322 |
| T510275-0005 | 5FAM-DEEIYEELK-NH2 | 5FAM-DEEIYEELK-NH2 | ≥95.0% | 5mg | ￥966 |
| T510276-0001 | 5FAM-QNPSRCSVSLSNVEA-NH2 | 5FAM-QNPSRCSVSLSNVEA-NH2 | ≥95.0% | 1mg | ￥438 |
| T510276-0005 | 5FAM-QNPSRCSVSLSNVEA-NH2 | 5FAM-QNPSRCSVSLSNVEA-NH2 | ≥95.0% | 5mg | ￥1314 |
| T510277-0001 | 5FAM-ERRKSKSGA-NH2 | 5FAM-ERRKSKSGA-NH2 | ≥95.0% | 1mg | ￥312 |
| T510277-0005 | 5FAM-ERRKSKSGA-NH2 | 5FAM-ERRKSKSGA-NH2 | ≥95.0% | 5mg | ￥936 |
PTH
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510080-0001 | Hypercalcemia Malignancy Factor (1-34), human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | ≥95.0% | 1mg | ￥578 |
| T510080-0005 | Hypercalcemia Malignancy Factor (1-34), human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | ≥95.0% | 5mg | ￥1734 |
| T510081-0001 | Hypercalcemia Malignancy Factor (1-34), amide, human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 | ≥95.0% | 1mg | ￥588 |
| T510081-0005 | Hypercalcemia Malignancy Factor (1-34), amide, human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 | ≥95.0% | 5mg | ￥1764 |
| T510082-0001 | Parathyroid Hormone (1-34), rat | AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF | ≥95.0% | 1mg | ￥578 |
| T510082-0005 | Parathyroid Hormone (1-34), rat | AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF | ≥95.0% | 5mg | ￥1734 |
| T510083-0001 | Parathyroid Hormone (1-34), bovine | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF | ≥95.0% | 1mg | ￥578 |
| T510083-0005 | Parathyroid Hormone (1-34), bovine | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF | ≥95.0% | 5mg | ￥1734 |
Renin Substrates & Inhibitors
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510084-0001 | Angiotensinogen (1-14), human | DRVYIHPFHLVIHN | ≥95.0% | 1mg | ￥210 |
| T510084-0005 | Angiotensinogen (1-14), human | DRVYIHPFHLVIHN | ≥95.0% | 5mg | ￥630 |
| T510085-0001 | Acetyl Angiotensinogen (1-14), porcine | Ac-DRVYIHPFHLLVYS | ≥95.0% | 1mg | ￥220 |
| T510085-0005 | Acetyl Angiotensinogen (1-14), porcine | Ac-DRVYIHPFHLLVYS | ≥95.0% | 5mg | ￥660 |
| T510086-0001 | Acetyl, Angiotensinogen (1-14), human | Ac-DRVYIHPFHLVIHN | ≥95.0% | 1mg | ￥220 |
| T510086-0005 | Acetyl, Angiotensinogen (1-14), human | Ac-DRVYIHPFHLVIHN | ≥95.0% | 5mg | ￥660 |
| T510087-0001 | Renin Substrate Tetradecapeptide, rat | DRVYIHPFHLLYYS | ≥95.0% | 1mg | ￥210 |
| T510087-0005 | Renin Substrate Tetradecapeptide, rat | DRVYIHPFHLLYYS | ≥95.0% | 5mg | ￥630 |
| T510088-0001 | Angiotensinogen (1-14), porcine | DRVYIHPFHLLVYS | ≥95.0% | 1mg | ￥210 |
| T510088-0005 | Angiotensinogen (1-14), porcine | DRVYIHPFHLLVYS | ≥95.0% | 5mg | ￥630 |
| T510089-0001 | Angiotensinogen (1-13), human | DRVYIHPFHLVIH | ≥95.0% | 1mg | ￥195 |
| T510089-0005 | Angiotensinogen (1-13), human | DRVYIHPFHLVIH | ≥95.0% | 5mg | ￥585 |
| T510090-0001 | P-H-P-F-H-F-F-V-Y-K | PHPFHFFVYK | ≥95.0% | 1mg | ￥150 |
| T510090-0005 | P-H-P-F-H-F-F-V-Y-K | PHPFHFFVYK | ≥95.0% | 5mg | ￥450 |
| T510278-0001 | [Cys8] Renin Substrate Tetradecapeptide, rat | DRVYIHPCHLLYYS | ≥95.0% | 1mg | ￥210 |
| T510278-0005 | [Cys8] Renin Substrate Tetradecapeptide, rat | DRVYIHPCHLLYYS | ≥95.0% | 5mg | ￥630 |
| T510279-0001 | [Leu8] Renin Substrate Tetradecapeptide, rat | DRVYIHPLHLLYYS | ≥95.0% | 1mg | ￥210 |
| T510279-0005 | [Leu8] Renin Substrate Tetradecapeptide, rat | DRVYIHPLHLLYYS | ≥95.0% | 5mg | ￥630 |
| T510280-0001 | [Val8] Renin Substrate Tetradecapeptide, rat | DRVYIHPVHLLYYS | ≥95.0% | 1mg | ￥210 |
| T510280-0005 | [Val8] Renin Substrate Tetradecapeptide, rat | DRVYIHPVHLLYYS | ≥95.0% | 5mg | ￥630 |
Secretins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510091-0001 | Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 | ≥95.0% | 1mg | ￥417 |
| T510091-0005 | Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 | ≥95.0% | 5mg | ￥1251 |
| T510092-0001 | Secretin (5-27), porcine | TFTSELSRLRDSARLQRLLQGLV-NH2 | ≥95.0% | 1mg | ￥332 |
| T510092-0005 | Secretin (5-27), porcine | TFTSELSRLRDSARLQRLLQGLV-NH2 | ≥95.0% | 5mg | ￥996 |
| T510281-0001 | Secretin, human | HSDGTFTSELSRLREGARLQRLLQGLV-NH2 | ≥95.0% | 1mg | ￥442 |
| T510281-0005 | Secretin, human | HSDGTFTSELSRLREGARLQRLLQGLV-NH2 | ≥95.0% | 5mg | ￥1362 |
Selank
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510308-0001 | Selank | TKPRPGP | ≥98.0% | 1mg | ￥108 |
| T510308-0005 | Selank | TKPRPGP | ≥98.0% | 5mg | ￥324 |
Somatostatin & Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510282-0001 | Somatostatin 28 (1-14) | SANSNPAMAPRERK | ≥95.0% | 1mg | ￥210 |
| T510282-0005 | Somatostatin 28 (1-14) | SANSNPAMAPRERK | ≥95.0% | 5mg | ￥630 |
| T510283-0001 | Somatostatin1-14 | AGCKNFFWKTFTSC (C3&C14 bridge) | ≥95.0% | 1mg | ￥320 |
| T510283-0005 | Somatostatin1-14 | AGCKNFFWKTFTSC (C3&C14 bridge) | ≥95.0% | 5mg | ￥960 |
| T510284-0001 | RC-160 (Vapreotide) | fCYwKVCW-NH2 (C2&C7 bridge) | ≥95.0% | 1mg | ￥300 |
| T510284-0005 | RC-160 (Vapreotide) | fCYwKVCW-NH2 (C2&C7 bridge) | ≥95.0% | 5mg | ￥900 |
| T510285-0001 | NTB (Naltriben) | DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) | ≥95.0% | 1mg | ￥300 |
| T510285-0005 | NTB (Naltriben) | DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) | ≥95.0% | 5mg | ￥900 |
Substance P & Analogs
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510286-0001 | [DPro2,DPhe7,DTrp9] Substance P | R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 | ≥95.0% | 1mg | ￥265 |
| T510286-0005 | [DPro2,DPhe7,DTrp9] Substance P | R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 | ≥95.0% | 5mg | ￥795 |
Substrate & Enzyme Inhibitors
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510093-0001 | MG-132 | RPKPQQFFGLM-NH2 | ≥95.0% | 1mg | ￥175 |
| T510093-0005 | MG-132 | RPKPQQFFGLM-NH2 | ≥95.0% | 5mg | ￥525 |
TAT Proteins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510287-0001 | Pep-1 | KETWWETWWTEWSQPKKKRKV | ≥95.0% | 1mg | ￥336 |
| T510287-0005 | Pep-1 | KETWWETWWTEWSQPKKKRKV | ≥95.0% | 5mg | ￥1008 |
| T510288-0001 | HIV-1 TAT Protein Peptide | YGRKKRRQRRR | ≥95.0% | 1mg | ￥165 |
| T510288-0005 | HIV-1 TAT Protein Peptide | YGRKKRRQRRR | ≥95.0% | 5mg | ￥495 |
| T510289-0001 | TAT 2-4 | YGRKKRRQRRRGYGRKKRRQRRRG | ≥95.0% | 1mg | ￥384 |
| T510289-0005 | TAT 2-4 | YGRKKRRQRRRGYGRKKRRQRRRG | ≥95.0% | 5mg | ￥1152 |
Thrombin Related Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510094-0001 | Scrambled TRAP Fragment | FSLLRN-NH2 | ≥95.0% | 1mg | ￥102 |
| T510094-0005 | Scrambled TRAP Fragment | FSLLRN-NH2 | ≥95.0% | 5mg | ￥306 |
| T510290-0001 | Hemoglobin (Hb) (64-76) | GKKVITAFNEGLK | ≥95.0% | 1mg | ￥195 |
| T510290-0005 | Hemoglobin (Hb) (64-76) | GKKVITAFNEGLK | ≥95.0% | 5mg | ￥585 |
Thymopoietin and Thymosin Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510292-0001 | Thymopoietin II (32-34) | RKD | ≥95.0% | 1mg | ￥60 |
| T510292-0005 | Thymopoietin II (32-34) | RKD | ≥95.0% | 5mg | ￥180 |
| T510293-0001 | Thymopoietin II (32-35) | RKDV | ≥95.0% | 1mg | ￥80 |
| T510293-0005 | Thymopoietin II (32-35) | RKDV | ≥95.0% | 5mg | ￥240 |
| T510294-0001 | Thymopentin | RKDVY | ≥95.0% | 1mg | ￥80 |
| T510294-0005 | Thymopentin | RKDVY | ≥95.0% | 5mg | ￥240 |
Urocortins
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510095-0001 | Urocortin II, human | IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 | ≥95.0% | 1mg | ￥748 |
| T510095-0005 | Urocortin II, human | IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 | ≥95.0% | 5mg | ￥2244 |
| T510096-0001 | Urocortin III, mouse | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 | ≥95.0% | 1mg | ￥694 |
| T510096-0005 | Urocortin III, mouse | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 | ≥95.0% | 5mg | ￥2082 |
| T510097-0001 | Urocortin III, human | FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 | ≥95.0% | 1mg | ￥694 |
| T510097-0005 | Urocortin III, human | FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 | ≥95.0% | 5mg | ￥2082 |
| T510098-0001 | Urocortin, human | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 | ≥95.0% | 1mg | ￥735 |
| T510098-0005 | Urocortin, human | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 | ≥95.0% | 5mg | ￥2205 |
| T510099-0001 | Urocortin, rat | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 | ≥95.0% | 1mg | ￥735 |
| T510099-0005 | Urocortin, rat | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 | ≥95.0% | 5mg | ￥2205 |
| T510100-0001 | Urocortin III, mouse, free acid | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI | ≥95.0% | 1mg | ￥684 |
| T510100-0005 | Urocortin III, mouse, free acid | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI | ≥95.0% | 5mg | ￥2052 |
| T510102-0001 | Urotensin I | NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 | ≥95.0% | 1mg | ￥738 |
| T510102-0005 | Urotensin I | NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 | ≥95.0% | 5mg | ￥2214 |
VIP
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510103-0001 | VIP, human, porcine, rat, ovine | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 | ≥95.0% | 1mg | ￥486 |
| T510103-0005 | VIP, human, porcine, rat, ovine | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 | ≥95.0% | 5mg | ￥1458 |
| T510104-0001 | PHI, rat | HADGVFTSDYSRLLGQISAKKYLESLI-NH2 | ≥95.0% | 1mg | ￥469 |
| T510104-0005 | PHI, rat | HADGVFTSDYSRLLGQISAKKYLESLI-NH2 | ≥95.0% | 5mg | ￥1407 |
| T510295-0001 | VIP, guinea pig | HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 | ≥95.0% | 1mg | ￥458 |
| T510295-0005 | VIP, guinea pig | HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 | ≥95.0% | 5mg | ￥1374 |
Virus Related Peptides
| 編號 | 名稱 | 序列（一個字母） | 純度 | 量 | ￥參考價 |
| T510105-0001 | Peptide T | ASTTTNYT | ≥95.0% | 1mg | ￥120 |
| T510105-0005 | Peptide T | ASTTTNYT | ≥95.0% | 5mg | ￥360 |
| T510106-0001 | R15K, HIV-1 Inhibitory Peptide | RIQRGPGRAFVTIGK | ≥95.0% | 1mg | ￥225 |
| T510106-0005 | R15K, HIV-1 Inhibitory Peptide | RIQRGPGRAFVTIGK | ≥95.0% | 5mg | ￥675 |
其他
| 編號 | 分類 | 名稱 | 序列（一個字母） | 純度 | ￥量 |
| T510296-0001 | 醋酸血管緊張素 | Angiotensin Acetate | NRVYVHPF | ≥98.0% | ￥1mg |
| T510296-0005 | 醋酸血管緊張素 | Angiotensin Acetate | NRVYVHPF | ≥98.0% | ￥5mg |
| T510297-0001 | 醋酸精氨酸加壓素 | Argpressin Acetate | c[CYFQNC]-PRG-NH2 | ≥98.0% | ￥1mg |
| T510297-0005 | 醋酸精氨酸加壓素 | Argpressin Acetate | c[CYFQNC]-PRG-NH2 | ≥98.0% | ￥5mg |
| T510298-0001 | 醋酸去氨加壓素(DDAVP) | Desmopressin Acetate | c[Mpr-YFQNC]PrG-NH2 | ≥98.0% | ￥1mg |
| T510298-0005 | 醋酸去氨加壓素(DDAVP) | Desmopressin Acetate | c[Mpr-YFQNC]PrG-NH2 | ≥98.0% | ￥5mg |
| T510299-0001 | 醋酸戈那瑞林 | Gonadorelin Acetate | Glp-HWSYGLRPG-NH2 | ≥98.0% | ￥1mg |
| T510299-0005 | 醋酸戈那瑞林 | Gonadorelin Acetate | Glp-HWSYGLRPG-NH2 | ≥98.0% | ￥5mg |
| T510300-0001 | 醋酸賴加壓素 | Lysipressin Acetate | C[CYFQNC]-PKG-NH2 | ≥98.0% | ￥1mg |
| T510300-0005 | 醋酸賴加壓素 | Lysipressin Acetate | C[CYFQNC]-PKG-NH2 | ≥98.0% | ￥5mg |
| T510301-0001 | 醋酸催產素 | Oxytocin Acetate | C[CYIQNC]PLG-NH2 | ≥98.0% | ￥1mg |
| T510301-0005 | 醋酸催產素 | Oxytocin Acetate | C[CYIQNC]PLG-NH2 | ≥98.0% | ￥5mg |
| T510302-0001 | 醋酸生長抑素 | Somatostatin Acetate | AG-c[CKNFFWKTFTSC]-OH | ≥98.0% | ￥1mg |
| T510302-0005 | 醋酸生長抑素 | Somatostatin Acetate | AG-c[CKNFFWKTFTSC]-OH | ≥98.0% | ￥5mg |
| T510303-0001 | 醋酸特利加壓素 | Terlipressin Acetate | GGGc[CYFQNC]PKG-NH2 | ≥98.0% | ￥1mg |
| T510303-0005 | 醋酸特利加壓素 | Terlipressin Acetate | GGGc[CYFQNC]PKG-NH2 | ≥98.0% | ￥5mg |
| T510304-0001 | 醋酸曲普瑞林 | Triptorelin Acetate | Glp-HWSYwLRPG-NH2 | ≥98.0% | ￥1mg |
| T510304-0005 | 醋酸曲普瑞林 | Triptorelin Acetate | Glp-HWSYwLRPG-NH2 | ≥98.0% | ￥5mg |
| T510305-0001 | 醋酸生長激素釋放肽-6 | GHRP-6 Acetate | HwAWfK-NH2 | ≥98.0% | ￥1mg |
| T510305-0005 | 醋酸生長激素釋放肽-6 | GHRP-6 Acetate | HwAWfK-NH2 | ≥98.0% | ￥5mg |
| T510306-0001 | 醋酸美拉諾坦I | Melanotan I Acetate | Ac-SYS-Nle-QHfRWGKPV-NH2 | ≥98.0% | ￥1mg |
| T510306-0005 | 醋酸美拉諾坦I | Melanotan I Acetate | Ac-SYS-Nle-QHfRWGKPV-NH2 | ≥98.0% | ￥5mg |
| T510309-0001 | 醋酸阿基瑞林 | Argreline Acetate | Ac-EEMQRR-NH2 (Acetyl Hexapeptide-3) | ≥98.0% | ￥1mg |
| T510309-0005 | 醋酸阿基瑞林 | Argreline Acetate | Ac-EEMQRR-NH2 (Acetyl Hexapeptide-3) | ≥98.0% | ￥5mg |
| T510310-0001 | 棕櫚酸五勝肽 | Palmitoyl Pentapeptide | Pal-KTTKS | ≥98.0% | ￥1mg |
| T510310-0005 | 棕櫚酸五勝肽 | Palmitoyl Pentapeptide | Pal-KTTKS | ≥98.0% | ￥5mg |
| T510311-0001 | 八勝肽 | SNAP-8 | Ac-EEMQRRAD-NH2 | 95.0%-98.0% | ￥1mg |
| T510311-0005 | 八勝肽 | SNAP-8 | Ac-EEMQRRAD-NH2 | 95.0%-98.0% | ￥5mg |